Evaluation of electronic PRO application system
- Conditions
- Neoplasms
- Registration Number
- KCT0007220
- Lead Sponsor
- Samsung Medical Center
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- ot yet recruiting
- Sex
- All
- Target Recruitment
- 372
1) 20 years of age or older (if necessary due to the nature of the disease, people aged 70 or older may be included in this study with the consent of their caregivers according to the decision of the healthcare professionals)
2) diagnosed with breast, endometrial, colon, or lung cancer;
planning to receive the first cycle of therapy (for both curative and palliative intent) or one year has been passed after the end of therapy (for curative intent only)
3) 0 or 1 in ECOG (Eastern Cooperative Oncology) performance status
4) capable to use a smartphone (Android OS only) and mobile applications
5) understanding the purpose of this study and expressing willingness to participate in this study
1) judged by the researcher to be restricted from participating in this study
2) planned to receive concurrent chemoradiation therapy (CCRT)
3) determined by the researcher to be unable to participate in this study
Study & Design
- Study Type
- Interventional Study
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method Changes in physical function between those who receive the symptom management during chemotherapy through the ePRO-CTCAE mobile application and those who does not.
- Secondary Outcome Measures
Name Time Method